The latest news

Stay up-to-date on all news concerning Medis and our software modalities

Medis QFR®, News

November 3, 2026

PIONEER IV Final Results Point to Adherence as the Key to Outcomes With Angiography-Derived Physiology

All, Medis Suite CT, News

November 1, 2026

NEW! Medis QGuideCT release

All, Medis Suite CT, News

November 1, 2026

P4 Trial: CT-Guided PCI Non-Inferior to IVUS Guidance, With Shorter Procedures

Medis Suite MR, News

September 22, 2026

Next-generation T1 & ECV Mapping

Medis QFR®, News

March 30, 2026

Another Major Study Reinforces Angiography-Derived Physiology as a Simpler Path to Optimal PCI

All, Medis QFR®, News

February 2, 2026

Medis Appoints Kevin DeMoss as VP Commercial QFR – North America to Support Clinical Adoption of Angiography Derived Coronary Physiology in the region

All, Medis QFR®, News

January 13, 2026

Medis announces the appointment of Regina Beyhl as Head of Marketing and Customer Experience.

All, Medis QFR®, News

September 1, 2025

PIONEER IV Trial Confirms Non-Inferiority of QFR-Guided PCI Compared to Usual Care Including FFR, iFR, IVUS and OCT Guidance

All, Medis QFR®, News

June 23, 2025

Medis Medical Imaging Welcomes Jason Fuller as Vice President of Sales, North America & Global Head of Customer Success

All, Medis QFR®, News

June 17, 2025

Medis Medical Imaging Appoints Martijn van Lavieren as Head of Clinical Strategy and Business Development.

All, Medis QFR®, News

May 23, 2025

FAVOR III Europe substudy confirms that Medis QFR® compares to the FFR standard

All, Medis QFR®, News

April 7, 2025

Medis QFR® 3.0 Launches in the U.S.

All, Medis QFR®, News

December 10, 2024

Terumo Health Outcomes and Medis Medical Imaging announce Strategic Partnership to enhance Cardiovascular Care

Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software

All, Medis QFR®, News

October 1, 2024

QFR® awarded Class I recommendation in 3 categories of the 2024 ESC guidelines for the management of Chronic Coronary Syndrome.

Medis’ Quantitative Flow Ratio (QFR®) has been awarded with a Class I recommendation in 3 distinct categories of the 2024

The latest news

PIONEER IV Final Results Point to Adherence as the Key to Outcomes With Angiography-Derived Physiology

NEW! Medis QGuideCT release

P4 Trial: CT-Guided PCI Non-Inferior to IVUS Guidance, With Shorter Procedures

Next-generation T1 & ECV Mapping

Another Major Study Reinforces Angiography-Derived Physiology as a Simpler Path to Optimal PCI

Medis Appoints Kevin DeMoss as VP Commercial QFR – North America to Support Clinical Adoption of Angiography Derived Coronary Physiology in the region

Medis announces the appointment of Regina Beyhl as Head of Marketing and Customer Experience.

PIONEER IV Trial Confirms Non-Inferiority of QFR-Guided PCI Compared to Usual Care Including FFR, iFR, IVUS and OCT Guidance

Medis Medical Imaging Welcomes Jason Fuller as Vice President of Sales, North America & Global Head of Customer Success

Medis Medical Imaging Appoints Martijn van Lavieren as Head of Clinical Strategy and Business Development.

FAVOR III Europe substudy confirms that Medis QFR® compares to the FFR standard

Medis QFR® 3.0 Launches in the U.S.

Terumo Health Outcomes and Medis Medical Imaging announce Strategic Partnership to enhance Cardiovascular Care

QFR® awarded Class I recommendation in 3 categories of the 2024 ESC guidelines for the management of Chronic Coronary Syndrome.

If you would like to keep up on the latest news, come by and connect with us on social media